Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Muhyi Al‐Sarraf, Michael LeBlanc, Padmini Giri et al. · Journal of Clinical Oncology · 1998 · 2.2K citations

Medicine, Oncology, Radiation Oncology +13

The hazard of accelerated tumor clonogen repopulation during radiotherapy

H. Rodney Withers, Jeremy M. G. Taylor, B. Maciejewski · Acta Oncologica · 1988 · 1.6K citations · Full text

Medicine, Oncology, Radiation Oncology +14

Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer

David M. Brizel, MARY ALBERS, Samuel R. Fisher et al. · New England Journal of Medicine · 1998 · 1.1K citations

Medicine, Oncology, Radiation Oncology +9

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

David M. Brizel, Gregory S. Sibley, Leonard R. Prosnitz et al. · International Journal of Radiation Oncology*Biology*Physics · 1997 · 1.1K citations

Medicine, Cancer Biology, Oncology +9

Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer

David M. Brizel, Todd H. Wasserman, Michael Henke et al. · Journal of Clinical Oncology · 2000 · 832 citations

Medicine, Oncology, Radiation Oncology +15